Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway
International Journal of Biological Sciences · 2026
DOI: 10.7150/ijbs.129604 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Xueqin Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, PR …. Hauptthemen laut MEDLINE: Quinolines, Indoles, Lung Neoplasms, Docetaxel. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, PR China.
- Department of Thoracic Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, PR China.
- Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, PR China.
- Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China.
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang 310018, PR China.
- School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, PR China.
Zitieren
APA
Chen, X., Shen, J., Xu, Z., Xu, B., Huang, J., Jiang, J., Chen, Y., Li, X., Yang, S., Wu, K., Wang, J., Luo, P., He, Q., Ma, S., Xia, B., & Yang, B. (2026). Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.129604
Vancouver
Chen X, Shen J, Xu Z, Xu B, Huang J, Jiang J, et al. Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.129604
BibTeX
@article{Chen2026,
author = {Chen, Xueqin and Shen, Juan and Xu, Zhifei and Xu, Bo and Huang, Jie and Jiang, Jingjing and Chen, Yidan and Li, Xin and Yang, Shaoyu and Wu, Kan and Wang, Jiaoli and Luo, Peihua and He, Qiaojun and Ma, Shenglin and Xia, Bing and Yang, Bo},
title = {Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway},
journal = {International Journal of Biological Sciences},
year = {2026},
doi = {10.7150/ijbs.129604}
}
EUVIMED